Optimizing Biosensor-based Trials

Drug development is moving beyond the clinic into real-world therapeutic evaluation—and ever closer to the patient’s daily life and medical needs. Applications of biosensors for remote data collection offer enormous opportunities to better engage patients in research and to deliver therapies that provide greater value for the patients who use them. In this report, Parexel shares insights on how to integrate multiple biosensors in a research approach that improves patient experience, delivers end-to-end remote data collection, and presages greater efficiencies that will ultimately reduce time to market.

Open PDF

Return to Insights Center

Related Insights


Highlights from ISMPP Asia Pacific Meeting 2021

Sep 20, 2021


Use of AI to develop health economic evidence for optimized patient access

Sep 6, 2023


Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data

Oct 15, 2021


Decentrally Speaking | Episode 1: Optimizing Trial Inclusivity For Patients From Under-Represented Communities

Mar 22, 2022


Clinical pharmacology, modeling and simulation to support FIH study design

Oct 21, 2021


Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021


CNS Summit Recap: The Future is Collaborative

Nov 22, 2021


How biotechs can strengthen their value story with advanced analytics

Feb 15, 2022


Toward more inclusive studies: Reaching and retaining patients from underrepresented communities

Apr 25, 2022


Capitalizing on sensors in clinical trials

Sep 20, 2021


Patients as Partners 2022: Moving from Insights to Action

May 3, 2022


Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients

May 3, 2022